시장보고서
상품코드
1429657

세계의 줄기세포 치료 시장 보고서(2024년)

Stem Cell Therapy Global Market Report 2024

발행일: | 리서치사: The Business Research Company | 페이지 정보: 영문 175 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    


■ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

줄기세포 치료 시장 규모는 향후 몇 년 동안 빠르게 성장할 것으로 예상됩니다. 2028년에는 13.4%의 연평균 복합 성장률(CAGR)로 131억 2,000만 달러에 달할 것으로 예상됩니다. 예측 기간 동안 예상되는 성장은 정부 지원 증가, 고령화 인구의 급속한 증가, 연구 개발 지출 증가, 의료 지출의 지속적인 증가에 기인할 수 있습니다. 이 기간 동안 예상되는 주요 동향으로는 간엽 줄기세포 치료의 진전을 면밀히 모니터링하고 이 분야의 혁신을 활용하는 데 중점을 두고 있습니다. 시장 관계자들은 제품 혁신을 촉진하고 수익을 촉진하기 위해 협업 및 인수에 참여할 것을 권장합니다. 또한, 기업들은 환자 치료를 위해 유도만능줄기세포(iPSC) 유래 자연살해(NK) 세포 개발에 투자하는 것을 고려해야 합니다. 줄기세포 치료 시장에서 특히 암 치료법 개발에 전략적으로 집중함으로써 체세포 경쟁사 대비 경쟁력을 강화할 수 있습니다. 마지막으로, 줄기세포 치료 시장의 기업들은 인공지능을 활용하여 제품 품질, 안전성 및 제조 생산성을 향상시킬 수 있습니다.

줄기세포 치료 시장의 성장은 만성질환의 유병률 증가에 크게 영향을 받습니다. 장시간 노동, 신체 활동의 제한, 건강에 해로운 식습관 등의 요인이 만성질환의 발병률 증가에 기여하고 있으며, 이는 줄기세포 치료에 대한 수요를 창출하고 있습니다. 유엔의 발표에 따르면, 2030년까지 전 세계 사망자의 70%가 만성질환으로 인한 사망자가 될 것으로 예측됩니다. 전 세계 만성질환의 부담은 약 60%에 달할 것으로 예상되며, 줄기세포 치료 시장의 성장을 더욱 가속화할 것으로 보입니다.

확대되고 있는 맞춤의료 분야는 줄기세포 치료 시장의 미래 성장을 견인할 태세를 갖추고 있습니다. 정밀의료라고도 불리는 맞춤의료는 유전자, 환경, 생활습관의 개인차를 고려하여 치료 계획을 조정하는 것을 포함합니다. 이 접근법은 개별 환자의 고유한 유전적 및 의학적 프로필에 따라 줄기세포 치료를 맞춤화함으로써 줄기세포 치료의 효과를 높입니다. 이는 치료 결과를 개선할 뿐만 아니라 부작용을 줄여 환자의 건강을 우선시합니다. 개인 맞춤형 의료의 환자 중심적 특성은 정확한 환자 선택, 보다 효과적인 임상시험, 시장 확대와 함께 줄기세포 치료의 매력을 높이고 시장 성장을 촉진하는 데 기여할 것으로 예상됩니다. 예를 들어, 2022년 식품의약국 의약품평가연구센터(CDER)는 37개의 새로운 분자 실체(NME)를 승인했으며, 그 중 약 34%(12개)가 개인맞춤의료연합(PMC)에 의해 개인맞춤의료로 분류되었습니다. 따라서 맞춤의료에 대한 관심이 높아지는 것은 줄기세포 치료 시장 확대의 중요한 원동력이 될 것입니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 거시경제 시나리오

  • 고인플레이션이 시장에 미치는 영향
  • 우크라이나·러시아 전쟁이 시장에 미치는 영향
  • COVID-19에 의한 시장에 대한 영향

제5장 세계 시장 규모와 성장

  • 세계의 시장 성장 촉진요인과 억제요인
    • 시장 성장 촉진요인
    • 시장 성장 억제요인
  • 세계의 시장 규모 실적과 성장, 2018-2023년
  • 세계의 시장 규모 예측과 성장, 2023-2028년, 2033년

제6장 시장 세분화

  • 세계의 줄기세포 치료 시장, 유형별 세분화, 실적 및 예측, 2018-2023년, 2023-2028년, 2033년
  • 동종 줄기세포 치료
  • 자가 줄기세포 치료
  • 세계의 줄기세포 치료 시장, 세포 유래별 세분화, 실적 및 예측, 2018-2023년, 2023-2028년, 2033년
  • 성체줄기세포
  • 유도만능줄기세포
  • 배아줄기세포
  • 세계의 줄기세포 치료 시장, 용도별 세분화, 실적 및 예측, 2018-2023년, 2023-2028년, 2033년
  • 근골격계 질환
  • 창상과 부상
  • 자가면역질환
  • 기타 용도
  • 세계의 줄기세포 치료 시장, 최종사용자별 세분화, 실적 및 예측, 2018-2023년, 2023-2028년, 2033년
  • 병원
  • 클리닉
  • 연구 센터
  • 기타

제7장 지역 및 국가 분석

  • 세계의 줄기세포 치료 시장, 지역별, 실적 및 예측, 2018-2023년, 2023-2028년, 2033년
  • 세계의 줄기세포 치료 시장, 국가별, 실적 및 예측, 2018-2023년, 2023-2028년, 2033년

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 상황과 기업 개요

  • 줄기세포 치료 시장 경쟁 상황
  • 줄기세포 치료 시장 기업 개요
    • Smith &Nephew Plc
    • Fujifilm Holding Corporation
    • Thermo Fisher Scientific Inc
    • Takara Bio Inc
    • MEDIPOST Co., Ltd.

제31장 기타 주요 및 혁신적인 기업

  • Astellas Pharma Inc.
  • Catalent, Inc.
  • Pharmicell Co., Ltd.
  • JCR Pharmaceuticals Co., Ltd.
  • Stemedica Cell Technologies, Inc.
  • Pluristem Technologies Ltd
  • Becton Dickinson Private Limited
  • Stem Cell Technologies India Pvt. Ltd
  • Cordlife India Pvt. Ltd
  • Lifecell International Pvt. Ltd
  • Stemcyte India Therapeutics Private Limited
  • Stempeutics Research Private Limited
  • Reelabs Private Limited
  • Anterogen Co., Ltd
  • Tonghua Dongbao Pharmaceutical Co

제32장 경쟁 벤치마킹

제33장 경쟁 대시보드

제34장 주요 인수합병

제35장 향후 전망과 가능성 분석

제36장 부록

ksm 24.03.21

Stem cell therapy is a branch of regenerative medicine that harnesses the power of stem cells or their derivatives to prompt the body's natural repair processes in damaged, malfunctioning, or injured tissues. It represents a significant advancement beyond organ transplantation, offering a viable alternative to scarce donor organs.

There are two primary types of stem cell therapy allogeneic stem cell therapy and autologous stem cell therapy. In allogeneic stem cell transplantation, stem cells are sourced from a healthy donor and transferred to the patient's body following intensive chemotherapy or radiation. The cells can be derived from various sources, including adult stem cells, induced pluripotent stem cells, and embryonic stem cells, and are employed in treating conditions such as musculoskeletal disorders, wounds and injuries, cancer, autoimmune disorders, among others. These therapies find application in hospitals and clinics.

The stem cell therapy market research report is one of a series of new reports from The Business Research Company that provides stem cell therapy market statistics, including stem cell therapy industry global market size, regional shares, competitors with a stem cell therapy market share, detailed stem cell therapy market segments, market trends and opportunities, and any further data you may need to thrive in the stem cell therapy industry. This stem cell therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The stem cell therapy market size has grown exponentially in recent years. It will grow from $6.43 billion in 2023 to $7.94 billion in 2024 at a compound annual growth rate (CAGR) of 23.5%. The historical period's growth can be ascribed to an increasing prevalence of chronic diseases, heightened funding from both governmental and private entities, rapid expansion in emerging markets, augmented investments in cell and gene therapies, a surge in healthcare expenditure, and a rise in pharmaceutical research and development expenditure.

The stem cell therapy market size is expected to see rapid growth in the next few years. It will grow to $13.12 billion in 2028 at a compound annual growth rate (CAGR) of 13.4%. The anticipated growth in the forecast period can be attributed to an increase in government support, a rapid rise in the aging population, heightened research and development spending, and a continued increase in healthcare expenditure. Key trends expected in this period involve a focus on closely monitoring advancements in mesenchymal stem cell therapy to leverage innovations in the field. Market players are advised to engage in collaborations and acquisitions to advance product innovation and drive revenues. Furthermore, companies should consider investments in the development of induced pluripotent stem cell (iPSC)-derived natural killer (NK) cells for patient treatment. In the stem cell therapy market, a strategic emphasis on developing therapies, particularly for cancer, can provide a competitive edge over somatic cell competitors. Lastly, companies in the stem cell therapy market are encouraged to harness artificial intelligence to enhance product quality, safety, and manufacturing productivity.

The growth of the stem cell therapy market is significantly influenced by the increasing prevalence of chronic diseases. Factors such as extended working hours, limited physical activity, and unhealthy dietary habits contribute to the rising incidence of chronic diseases, creating a demand for stem cell therapy. According to a United Nations article, it is projected that by 2030, chronic diseases will account for 70% of global deaths. The global burden of chronic diseases is expected to reach approximately 60%, further fueling the growth of the stem cell therapy market.

The expanding field of personalized medicine is poised to drive the future growth of the stem cell therapy market. Personalized medicine, also known as precision medicine, involves tailoring medical treatment plans to account for individual variations in genes, environment, and lifestyle. This approach enhances the effectiveness of stem cell treatments by customizing them based on the unique genetic and medical profiles of individual patients. This not only improves treatment outcomes but also reduces adverse effects, prioritizing patient well-being. The patient-centric nature of personalized medicine, coupled with precise patient selection, more effective clinical trials, and market expansion, contributes to the increasing appeal of stem cell therapies and is expected to propel market growth. For instance, in 2022, the Food and Drug Administration's Center for Drug Evaluation and Research (CDER) approved 37 new molecular entities (NMEs), with approximately 34% (12 of them) classified as personalized medicines by the Personalized Medicine Coalition (PMC). Consequently, the growing prominence of personalized medicine is a key driver for the expansion of the stem cell therapy market.

Companies within the stem cell therapy market are increasingly engaging in strategic partnerships, representing mutually beneficial agreements between entities that do not directly compete. A notable example is the partnership formed in May 2022 between SQZ Biotechnologies, a US-based biotechnology company, and STEMCELL Technologies Inc., a Canada-based biotechnology company. This collaboration aims to develop and commercialize a research-use-only (RUO) microfluidic intracellular delivery system based on SQZ's Cell Squeeze technology. The partnership is geared towards providing the life sciences community with enhanced cell engineering capabilities for preclinical research. SQZ Biotechnologies and STEMCELL Technologies Inc. are expected to present significant findings demonstrating the potential of the RUO system in efficiently delivering cargoes to primary immune cell types, showcasing advancements in cell engineering with mRNA and CRISPR/Cas9 in hematopoietic stem cells.

Major players in the stem cell therapy market are directing their focus towards the development of innovative technologies, such as Induced Pluripotent Stem Cells (iPSC), to enhance the efficiency of stem cell therapies. iPSCs are derived from blood or skin cells that are reProgramd to an embryonic-such as pluripotent state, offering an unlimited source of various human cells crucial for stem cell therapeutic purposes. An example of this technology is the genome engineering platform for iPSCs launched by Synthego Corporation, a US-based genome engineering company, in October 2022. This platform provides an unprecedented level of editing efficiency for iPSCs on an industrial scale, facilitating precise modifications and creating disease models, including neurodegenerative conditions such as Alzheimer's disease. The platform enables the creation of high-quality, physiologically relevant biological models for translational medicine, promising advancements in research and therapeutic development.

In July 2022, Vertex Pharmaceuticals Inc., a US-based biotechnology company, made a significant acquisition by purchasing ViaCyte Pharma Inc. for $320 million. This acquisition strengthened Vertex Pharmaceuticals' commitment to developing transformative cell replacement therapies for type 1 diabetes. ViaCyte Pharma Inc., a US-based biotechnology company, focuses on innovative stem cell-derived cell replacement therapies, particularly for type 1 diabetes (T1D). The acquisition provided Vertex Pharmaceuticals with additional tools, technologies, stem cell lines, and manufacturing facilities, accelerating their ongoing programs in this field.

Major companies operating in the stem cell therapy market report are Smith & Nephew PLC, Fujifilm Holding Corporation, Thermo Fisher Scientific Inc., Takara Bio Inc., MEDIPOST Co., Ltd., Astellas Pharma Inc., Catalent, Inc., Pharmicell Co., Ltd., JCR Pharmaceuticals Co., Ltd., Stemedica Cell Technologies, Inc., Pluristem Technologies Ltd., Becton Dickinson Private Limited, Stem Cell Technologies India Pvt. Ltd., Cordlife India Pvt. Ltd., Lifecell International Pvt. Ltd., Stemcyte India Therapeutics Private Limited, Stempeutics Research Private Limited, Reelabs Private Limited, Anterogen Co., Ltd., Tonghua Dongbao Pharmaceutical Co, China Biologic Products Holdings Inc., Astrazenaca, Ablbio, Adimmune, Henlius, China Regenerative Medicine International, Innovent Biologics, Bio-Thera, Hisun Pharma, 3sbio, Beijing Shuanglu Pharmaceuticals, Qilu Pharmaceutical, Shanghai Fosun Pharmaceuticals , Cellerix, Cellgenix, Nsgene, Tigenix, Renuron Group, Smart Cells And Genenta Science, Amsterdam Molecular Therapeutics (Amt), Ark Therapeutics, Arthrogen Bv, Diamyd Medical Ab, Oxford Biomedica, Transgene, Mol Med, Selvita, Mabion, Pure Biologics, Oncoarendi Therapeutics, Captor Therapeutics, Celon Pharma, Nanovelos, Dickinson And Company, Sigma Aldrich (A Subsidiary Of Merck Kgaa), Osiris Therapeutics, Capricortherapeutics, Cellular Dynamics Discgenics, Takeda Pharmaceuticals, Kolon Tissue Gene, Athersys, Cyro-Cell International, Geron Corporation, Mesoblast Ltd., Astrom Biosciences Inc., Celgene Corporation, Invitrogen, Cytori Therapeutics Inc., Nuvasive Inc., Bristol-Myers Squibb Aldagen Inc., Caladrius Biosciences Inc., Adcock Ingram, Bayer East Africa Ltd., Biogen Sa, Daiichi Sankyo Co. Ltd., Gamida Cell Ltd., Gilead Sciences, Inc., Novartis Ag, Pfizer, Sanofi

North America was the largest region in the stem cell therapy market in 2023. The Middle East is expected to be the fastest-growing region in the global stem cell therapy market during the forecast period. The regions covered in the stem cell therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the stem cell therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

The stem cell therapy market includes revenues earned by entities by hematopoietic stem cells, skin stem cells, neural stem cells, and mesenchymal stem cells. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Stem Cell Therapy Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on stem cell therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for stem cell therapy? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The stem cell therapy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Type: Allogeneic Stem Cell Therapy; Autologous Stem Cell Therapy
  • 2) By Cell Source: Adult Stem Cells; Induced Pluripotent Stem Cells; Embryonic Stem Cells
  • 3) By Application: Musculoskeletal Disorders and Wounds & Injuries; Cancer; Autoimmune Disorders; Others
  • 4) By End-Users: Hospitals And Clinics; Research Centers; Others.
  • Companies Mentioned: Smith & Nephew Plc; Fujifilm Holding Corporation; Thermo Fisher Scientific Inc; Takara Bio Inc; MEDIPOST Co., Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Stem Cell Therapy Market Characteristics

3. Stem Cell Therapy Market Trends And Strategies

4. Stem Cell Therapy Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Stem Cell Therapy Market Size and Growth

  • 5.1. Global Stem Cell Therapy Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Stem Cell Therapy Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Stem Cell Therapy Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Stem Cell Therapy Market Segmentation

  • 6.1. Global Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Allogeneic Stem Cell Therapy
  • Autologous Stem Cell Therapy
  • 6.2. Global Stem Cell Therapy Market, Segmentation By Cell Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Adult Stem Cells
  • Induced Pluripotent Stem Cells
  • Embryonic Stem Cells
  • 6.3. Global Stem Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Musculoskeletal Disorders
  • Wounds and Injuries
  • Cancer
  • Autoimmune Disorders
  • Other Applications
  • 6.4. Global Stem Cell Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Clinics
  • Research Centers
  • Others

7. Stem Cell Therapy Market Regional And Country Analysis

  • 7.1. Global Stem Cell Therapy Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Stem Cell Therapy Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Stem Cell Therapy Market

  • 8.1. Asia-Pacific Stem Cell Therapy Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Stem Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Stem Cell Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Stem Cell Therapy Market

  • 9.1. China Stem Cell Therapy Market Overview
  • 9.2. China Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Stem Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Stem Cell Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Stem Cell Therapy Market

  • 10.1. India Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Stem Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Stem Cell Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Stem Cell Therapy Market

  • 11.1. Japan Stem Cell Therapy Market Overview
  • 11.2. Japan Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Stem Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Stem Cell Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Stem Cell Therapy Market

  • 12.1. Australia Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Stem Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Stem Cell Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Stem Cell Therapy Market

  • 13.1. Indonesia Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Stem Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Stem Cell Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Stem Cell Therapy Market

  • 14.1. South Korea Stem Cell Therapy Market Overview
  • 14.2. South Korea Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Stem Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Stem Cell Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Stem Cell Therapy Market

  • 15.1. Western Europe Stem Cell Therapy Market Overview
  • 15.2. Western Europe Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Stem Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Stem Cell Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Stem Cell Therapy Market

  • 16.1. UK Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Stem Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Stem Cell Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Stem Cell Therapy Market

  • 17.1. Germany Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Stem Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Stem Cell Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Stem Cell Therapy Market

  • 18.1. France Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Stem Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Stem Cell Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Stem Cell Therapy Market

  • 19.1. Italy Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Stem Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Stem Cell Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Stem Cell Therapy Market

  • 20.1. Spain Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Stem Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Stem Cell Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Stem Cell Therapy Market

  • 21.1. Eastern Europe Stem Cell Therapy Market Overview
  • 21.2. Eastern Europe Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Stem Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Stem Cell Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Stem Cell Therapy Market

  • 22.1. Russia Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Stem Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Stem Cell Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Stem Cell Therapy Market

  • 23.1. North America Stem Cell Therapy Market Overview
  • 23.2. North America Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Stem Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Stem Cell Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Stem Cell Therapy Market

  • 24.1. USA Stem Cell Therapy Market Overview
  • 24.2. USA Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Stem Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Stem Cell Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Stem Cell Therapy Market

  • 25.1. Canada Stem Cell Therapy Market Overview
  • 25.2. Canada Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Stem Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Stem Cell Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Stem Cell Therapy Market

  • 26.1. South America Stem Cell Therapy Market Overview
  • 26.2. South America Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Stem Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Stem Cell Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Stem Cell Therapy Market

  • 27.1. Brazil Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Stem Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Stem Cell Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Stem Cell Therapy Market

  • 28.1. Middle East Stem Cell Therapy Market Overview
  • 28.2. Middle East Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Stem Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Stem Cell Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Stem Cell Therapy Market

  • 29.1. Africa Stem Cell Therapy Market Overview
  • 29.2. Africa Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Stem Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Stem Cell Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Stem Cell Therapy Market Competitive Landscape And Company Profiles

  • 30.1. Stem Cell Therapy Market Competitive Landscape
  • 30.2. Stem Cell Therapy Market Company Profiles
    • 30.2.1. Smith & Nephew Plc
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Fujifilm Holding Corporation
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Thermo Fisher Scientific Inc
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Takara Bio Inc
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. MEDIPOST Co., Ltd.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Stem Cell Therapy Market Other Major And Innovative Companies

  • 31.1. Astellas Pharma Inc.
  • 31.2. Catalent, Inc.
  • 31.3. Pharmicell Co., Ltd.
  • 31.4. JCR Pharmaceuticals Co., Ltd.
  • 31.5. Stemedica Cell Technologies, Inc.
  • 31.6. Pluristem Technologies Ltd
  • 31.7. Becton Dickinson Private Limited
  • 31.8. Stem Cell Technologies India Pvt. Ltd
  • 31.9. Cordlife India Pvt. Ltd
  • 31.10. Lifecell International Pvt. Ltd
  • 31.11. Stemcyte India Therapeutics Private Limited
  • 31.12. Stempeutics Research Private Limited
  • 31.13. Reelabs Private Limited
  • 31.14. Anterogen Co., Ltd
  • 31.15. Tonghua Dongbao Pharmaceutical Co

32. Global Stem Cell Therapy Market Competitive Benchmarking

33. Global Stem Cell Therapy Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Stem Cell Therapy Market

35. Stem Cell Therapy Market Future Outlook and Potential Analysis

  • 35.1 Stem Cell Therapy Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Stem Cell Therapy Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Stem Cell Therapy Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제